Radiation Dose De-Escalation in HPV-Positive Oropharynx Cancer: When Will It Be an Acceptable Standard of Care?

被引：10

作者：

Chundury, Anupama ^{[1
]}

Kim, Sung ^{[1
]}

机构：

[1] Rutgers Canc Inst New Jersey, 195 Little Albany St, New Brunswick, NJ 08831 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 09期

关键词：

SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; HEAD; SURVIVAL; TRIAL;

D O I：

10.1200/JCO.21.00017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[21] Dose and volume de-escalation of radiotherapy in head and neck cancer [J].

Garcia-Anaya, M. J. ;

Segado-Guillot, S. ;

Cabrera-Rodriguez, J. ;

Toledo-Serrano, M. D. ;

Medina-Carmona, J. A. ;

Gomez-Millan, J. .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 186

[22] Role of TORS as De-Escalation Strategy in HPV-Related Oropharyngeal Cancer, What We Need to Know [J].

Molteni, Gabriele ;

Bassani, Sara ;

Arsie, Athena Eliana ;

Zampieri, Erica ;

Mannelli, Giuditta ;

Orlandi, Ester ;

Bossi, Paolo ;

De Virgilio, Armando .

HEALTHCARE, 2024, 12 (10)

[23] Enhanced Radiation Sensitivity in HPV-Positive Head and Neck Cancer [J].

Kimple, Randall J. ;

Smith, Molly A. ;

Blitzer, Grace C. ;

Torres, Alexandra D. ;

Martin, Joshua A. ;

Yang, Robert Z. ;

Peet, Chimera R. ;

Lorenz, Laurel D. ;

Nickel, Kwangok P. ;

Klingelhutz, Aloysius J. ;

Lambert, Paul F. ;

Harari, Paul M. .

CANCER RESEARCH, 2013, 73 (15) :4791-4800

[24] IMRT - Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer [J].

Andreassen, C. N. ;

Eriksen, J. G. ;

Jensen, K. ;

Hansen, C. R. ;

Sorensen, B. S. ;

Lassen, P. ;

Alsner, J. ;

Schack, L. M. H. ;

Overgaard, J. ;

Grau, C. .

ORAL ONCOLOGY, 2018, 86 :91-99

[25] Dose De-escalation to the Elective Lymph Nodes in Head and Neck Cancer [J].

Nevens, D. ;

Duprez, F. ;

Daisne, J. F. ;

De Neve, W. ;

Nuyts, S. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (03) :746-747

[26] Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynx [J].

Dobrosotskaya, Irina Y. ;

Bellile, Emily ;

Spector, Matthew E. ;

Kumar, Bhavna ;

Feng, Felix ;

Eisbruch, Avraham ;

Wolf, Gregory T. ;

Prince, Mark E. P. ;

Moyer, Jeffrey S. ;

Teknos, Theodoros ;

Chepeha, Douglas B. ;

Walline, Heather M. ;

McHugh, Jonathan B. ;

Cordell, Kitrina G. ;

Ward, Daniel ;

Byrd, Serena ;

Maxwell, Jessica H. ;

Urba, Susan ;

Bradford, Carol R. ;

Carey, Thomas E. ;

Worden, Francis P. .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (05) :617-623

[27] HPV-associated oropharyngeal cancer de-escalation strategies and trials: Past failures and future promise [J].

Zakeri, Kaveh ;

Dunn, Lara ;

Lee, Nancy .

JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (06) :962-966

[28] Dose De-escalation to the Elective Lymph Nodes in Head and Neck Cancer Reply [J].

Maguire, Patrick D. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (03) :747-747

[29] Should de-escalation of bone-targeting agents be standard of care? [J].

Awan, A. ;

Hutton, B. ;

Clemons, M. .

ANNALS OF ONCOLOGY, 2018, 29 (05) :1333-1334

[30] Adjuvant Radiation Sparing after Neoadjuvant Chemotherapy and TORS in Selected HPV-Positive Oropharyngeal Cancer [J].

Costantino, Andrea ;

Sampieri, Claudio ;

Sim, Nam Suk ;

De Virgilio, Armando ;

Kim, Se-Heon .

LARYNGOSCOPE, 2025, 135 (04) :1401-1408

← 1 2 3 4 5 →